Where can I find news about OSSUY?

The latest headlines, third-party analysis, and SEC filings for Embla Medical hf. (OSSUY) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.

Where are OSSUY's SEC filings?

Embla Medical hf. (OSSUY)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.

Where are OSSUY's earnings call transcripts?

Full earnings call transcripts for Embla Medical hf. (OSSUY) — prepared remarks plus speaker-by-speaker analyst Q&A — live on the Earnings tab, alongside the Earnings Reports section that links each quarter's press release and SEC report.

OSSUY

Embla Medical hf.

OTC·Medical, Devices · Healthcare

$4.15$0.00+0.00%

Market cap$1.77B·Market closed·Aug 26 8:00 PM UTC

News & Analysis

Embla Medical hf. (OSSUY) Q2 2026 Earnings Call Transcript
Embla Medical hf. (OSSUY) Q2 2026 Earnings Call Transcript
seekingalpha.comJul 21, 2026 · 6:43 AM
Embla Medical hf. (OSSUY) Q1 2026 Earnings Call Transcript
Embla Medical hf. (OSSUY) Q1 2026 Earnings Call Transcript
seekingalpha.comApr 28, 2026 · 7:01 AM
Embla Medical hf. (OSSUY) Q4 2025 Earnings Call Transcript
Embla Medical hf. (OSSUY) Q4 2025 Earnings Call Transcript
seekingalpha.comFeb 3, 2026 · 12:30 PM
Embla Medical hf. (OSSUY) Q3 2025 Earnings Call Transcript
Embla Medical hf. (OTCPK:OSSUY) Q3 2025 Earnings Call October 21, 2025 3:00 AM EDT Company Participants Sveinn Sölvason - President & CEO Gudny Sveinsdottir - Chief Financial Officer Conference Call Participants Jesper Ingildsen - DNB Carnegie, Research Division Tobias Nissen - Danske Bank A/S, Research Division Martin Brenoe - Nordea Markets, Research Division Yiwei Zhou - SEB, Research Division Presentation Operator At this time, I would like to welcome everyone to this Q3 2025 conference call.
seekingalpha.comOct 21, 2025 · 12:34 PM
Embla Medical hf: Embla Medical signs agreement to invest in a majority share in Streifeneder ortho.production GmbH
Announcement no. 31/2025 17 July 2025 REYKJAVIK, Iceland and COPENHAGEN, Denmark , July 17, 2025 /PRNewswire/ -- Embla Medical (NASDAQ Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today signed an agreement to invest in a majority share (51% of the shares) in privately owned Streifeneder ortho.production GmbH ("Streifeneder").
prnewswire.comJul 17, 2025 · 8:25 AM

SEC Filings

No recent filings indexed.

Frequently Asked Questions About OSSUY

Where can I find news about OSSUY?: The latest headlines, third-party analysis, and SEC filings for Embla Medical hf. (OSSUY) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.
Where are OSSUY's SEC filings?: Embla Medical hf. (OSSUY)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.
Where are OSSUY's earnings call transcripts?: Full earnings call transcripts for Embla Medical hf. (OSSUY) — prepared remarks plus speaker-by-speaker analyst Q&A — live on the Earnings tab, alongside the Earnings Reports section that links each quarter's press release and SEC report.

Embla Medical hf.

Frequently Asked Questions About OSSUY

Embla Medical hf.

Embla Medical hf. (OSSUY) Q2 2026 Earnings Call Transcript

Embla Medical hf. (OSSUY) Q1 2026 Earnings Call Transcript

Embla Medical hf. (OSSUY) Q4 2025 Earnings Call Transcript

Embla Medical hf. (OSSUY) Q3 2025 Earnings Call Transcript

Embla Medical hf: Embla Medical signs agreement to invest in a majority share in Streifeneder ortho.production GmbH

Frequently Asked Questions About OSSUY

Embla Medical hf. (OSSUY) Q2 2026 Earnings Call Transcript

Embla Medical hf. (OSSUY) Q1 2026 Earnings Call Transcript

Embla Medical hf. (OSSUY) Q4 2025 Earnings Call Transcript

Embla Medical hf. (OSSUY) Q3 2025 Earnings Call Transcript

Embla Medical hf: Embla Medical signs agreement to invest in a majority share in Streifeneder ortho.production GmbH